Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Co-stimulatory molecules are cell surface proteins expressed on immune cells—primarily T cells and antigen-presenting cells—that provide essential secondary signals required for full T cell activation. The primary signal is delivered through the T cell receptor upon recognition of an antigen presented by major histocompatibility complex (MHC) molecules. The secondary "co-stimulatory" signal is necessary to prevent T cell anergy or apoptosis and to promote effective immune responses. Key examples include CD28, which interacts with CD80 and CD86 on antigen-presenting cells, and other families such as ICOS/ICOSL and members of the TNF-receptor superfamily. These molecules play critical roles in determining whether an immune response will be activated or tolerance induced. Dysregulation can lead to autoimmunity, immunodeficiency, cancer progression, or transplant rejection[1][2][3][4]. Note: "Co-stimulatory molecule" refers to a broad functional category rather than a single molecular entity; it encompasses multiple distinct proteins with related but non-identical functions. The term "co-stimulatory molecule" does not refer to one unique molecular target but rather describes a large group/family of functionally related proteins involved in immune regulation[1][2]. Therefore: is_incorrect is set to true because this entry lacks specificity—it should be replaced by more precise canonical names such as "CD28," "Inducible T-cell costimulator," etc., depending on context. Entries like interacting_drugs, mechanism_of_action, biomarkers, and safety_concerns cannot be meaningfully filled at the class level without specifying which member(s) are meant. If you need structured information about specific co-stimulatory targets (e.g., CD28), please specify that target directly for accurate data extraction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Co-stimulatory molecule.